Figure 1: Pharmaceutical Market, Australia, Revenue ($B and AUDB), 2013–2020
Figure 2: Medical Devices Market, Australia, Revenue ($B), 2016–2020
Figure 3: Healthcare Startups in Australia, 2020
Figure 4: Country Profile, Australia, 2020
Figure 5: Pharmaceutical Market, Australia, Revenue ($B and AUDB), 2013–2020
Figure 6: Pharmaceutical Market, Australia, Revenue Forecast ($B and AUDB), 2021–2026
Figure 7: Pharmaceutical Exports ($B), Australia, 2013–2020
Figure 8: Top Export Partners, Australia, 2020
Figure 9: Pharmaceutical Imports ($B), Australia, 2013–2020
Figure 10: Top Import Partners, Australia, 2020
Figure 11: Pharmaceutical Supply Channel, Australia, 2021
Figure 12: Process of eTP, Australia, 2021
Figure 13: Principles of GBMA, Australia, 2021
Figure 14: Facts Regarding Generics, Australia, 2021
Figure 15: Working of Price Disclosure, Australia, 2021
Figure 16: Number of Biosimilars Approved, Australia, 2010-2021
Figure 17: OTC Market, Revenue ($B), Australia, 2013–2020
Figure 18: OTC Medicines Market, Major Distribution Channels ($M), Australia, 2020
Figure 19: OTC Medicines Market, Major Categories ($M), Australia, 2020
Figure 20: Major Therapeutic Areas by Production Value, Australia, 2019
Figure 21: COVID-19 Cases, Australia, 2020–2021
Figure 22: COVID-19 Deaths, Australia, 2020–2021
Figure 23: COVID-19 Stringency Index, Australia, 2020–2021
Figure 24: Containment and Health Index, COVID-19, Australia, 2020–2021
Figure 25: COVID-19 Fiscal Stimulus Timeline, Australia, 2020–2021
Figure 26: COVID-19 Vaccine Doses Administration, Number of Vaccine Doses Administered, Australia, 2021
Figure 27: Five Key Areas of Australia’s COVID-19 Vaccine and Treatment Strategy, Australia, 2020–2021
Figure 28: COVID-19 Vaccine Plan, Australia, 2021
Figure 29 Objectives of COVID-19 Vaccine Safety Monitoring Plan, Australia, 2021
Figure 30: Vaccine Doses, Australia, 2021
Figure 31: National Plan to Transition Australia’s National COVID-19 Response, Australia, 2021
Figure 32: Top COVID-19 Markets by Product Categories (Number of Available Marketed Products), Australia, 2020–2021
Figure 33: Top COVID-19 Products by Device Class (Number of Available Marketed Products), Australia, 2020–2021
Figure 34: Top COVID-19 IVD Products by Equipment Type (Number of Available Marketed Products), Australia, 2020–2021
Figure 35: Top COVID-19 Hospital Supplies Products by Equipment Type (Number of Available Marketed Products), Australia, 2020–2021
Figure 36: COVID-19 Clinical Trials Count by Trial Status, Australia, 2020–2021
Figure 37: COVID-19 Clinical Trials Count by Market Categories, Australia, 2020–2021
Figure 38: Top COVID-19 Clinical Trials Sponsors by Trial Count, Australia, 2020–2021
Figure 39: Medical Devices Market, Australia, Revenue ($B), 2016–2020
Figure 40: Medical Devices Market, Australia, Revenue ($B), 2021–2027
Figure 41: Medical Devices Market, Australia, Major Segments (%), 2020
Figure 42: Hospital Supplies Market, Australia, Revenue ($B), 2017–2025
Figure 43: Hospital Supplies Market, Australia, Market Share of Major Players (%), 2020
Figure 44: Orthopedic Devices Market, Australia, Revenue ($B), 2017–2025
Figure 45: Orthopedic Devices Market, Australia, Market Share of Major Players (%), 2020
Figure 46: General Surgery Devices Market, Australia, Revenue ($B), 2017-2025
Figure 47: General Surgery Devices Market, Australia, Market Share of Major Players (%), 2020
Figure 48: Cardiovascular Devices Market, Australia, Revenue ($B), 2017–2025
Figure 49: Cardiovascular Devices Market, Australia, Market Share of Major Players (%), 2020
Figure 50: Anesthesia and Respiratory Devices Market, Australia, Revenue ($B), 2017–2025
Figure 51: Anesthesia and Respiratory Devices Market, Australia, Market Share of Major Players (%), 2020
Figure 52: Diagnostic Market, Australia, Revenue ($B), 2015–2020
Figure 53: Diagnostic Market, Australia, Revenue ($B), 2021–2025
Figure 54: Medical Devices Market, Australia, Revenue ($B) of Major Companies, 2020
Figure 55: Deal Value and Deal Count, Pharmaceutical Market, Australia, 2020–2021
Figure 56: Deal Value and Deal Count Subtypes, Pharmaceutical Market, Australia, 2020–2021
Figure 57: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Australia, 2020–2021
Figure 58: Top Therapy Areas by Deal Value, Pharmaceutical Market, Australia, 2020–2021
Figure 59: Top Therapy Areas by Deal Count, Pharmaceutical Market, Australia, 2020–2021
Figure 60: M&A Deals by Quarter, Pharmaceutical Market, Australia, 2020–2021 (by Value and by Number)
Figure 61: VC Deals by Quarter, Pharmaceutical Market, Australia, 2020–2021 (by Value and by Number)
Figure 62: Deal Value and Deal Count, Medical Devices Market, Australia, 2020–2021
Figure 63: Deal Value and Deal Count Subtypes, Medical Devices Market, Australia, 2020–2021
Figure 64: Deal Value and Deal Count, Quarterly, Medical Devices Market, Australia, 2020–2021
Figure 65: Top Equipment Sectors by Deal Value, Medical Devices Market, Australia, 2020–2021
Figure 66: Top Equipment Sectors by Deal Count, Medical Devices Market, Australia, 2020–2021
Figure 67: M&A Deals by Quarter, Medical Devices Market, Australia, 2020–2021 (by Value and by Number)
Figure 68: VC Deals by Quarter, Medical Devices Market, Australia, 2020–2021 (by Value and by Number)
Figure 69: Benefits of Digital Health, Australia, 2020
Figure 70: Deal Value ($M) and Deal Count, HealthTech, Australia, 2020–2021
Figure 71: Deal Value and Deal Count (Number of Deals) by sector, HealthTech, Australia, 2020–2021
Figure 72: Key Themes of Australia’s National Digital Health Strategy, Australia, 2020
Figure 73: Strategic Priorities of Australia’s National Digital Health Strategy, Australia, 2020
Figure 74: Digital Health Today and Future Timeline as per the Digital Health Strategy, Australia, 2020
Figure 75: Organization of Healthcare System, Australia, 2021
Figure 76: HTA Process of Market Entry and Reimbursement, Australia, 2021
Figure 77: Proportion of Benefits Paid by Hospital Cover Private Health Insurance by Service Type, (in $M) Australia, 2018–2019
Figure 78: Proportion of Benefits Paid by General Cover Private Health Insurance by Service Type (in $M), Australia, 2018–2019
Figure 79: OOP Expenditure (% of Total Expenditure on Health), Australia, 2013–2020
Figure 80: Annual Rate of Change (%), Consumer Price Index, Australia, 2013–2021
Figure 81: Organization of TGA, Australia, 2021
Figure 82: Phases and Milestones of Registration of Prescription Medicines, Australia, 2021
Figure 83 Process of Registration of OTC, Australia, 2021
Figure 84: Process of Registration of Complimentary Medicines, Australia, 2021
Figure 85: Process of Registration of Medical Devices, Australia, 2021
Figure 86: Patent Approval Process, Australia, 2021
Figure 87: Trademark Approval Process, Australia, 2021
Figure 88: Fees for the CTN and CTA schemes of Clinical Trials, Australia, 2021
Figure 89: Pharmaceutical Clinical Trials Count by Trial Status, Australia, 2020–2021
Figure 90: Pharmaceutical Clinical Trials Count by Therapy Area, Australia, 2020–2021
Figure 91: Pharmaceutical Clinical Trials Count by Phase, Australia, 2020–2021
Figure 92: Pharmaceutical Clinical Trials Count by Sponsors, Australia, 2020–2021
Figure 93: Medical Devices Clinical Trials Count by Trial Status, Australia, 2020–2021
Figure 94: Medical Devices Clinical Trials Count by Device Category, Australia, 2020–2021
Figure 95: Medical Devices Clinical Trials Count by Indication, Australia, 2020–2021
Figure 96: Medical Devices Clinical Trials Sponsors by Count, Australia, 2020–2021
Figure 97: Process of Licensing of Pharmaceutical Products, Australia, 2021
Figure 98: Export Procedure, Australia, 2021
Figure 99: Necessary Labelling on the Package, Australia, 2021
Figure 100: Types of Packaging of Drugs, Australia, 2021
Figure 101: Number of Hospitals, Australia, 2012–2019
Figure 102: Number of Diagnostic Equipment, Australia, 2013–2019
Figure 103: Hospital Beds (per 1,000 population), Australia, 2012–2019
Figure 104: Acute Care Hospital Beds (per 1,000 population), Australia, 2012–2019
Figure 105: Psychiatric Care Hospital Beds (per 1,000 population), Australia, 2012–2019
Figure 106: Life Expectancy at Birth (Years), Australia, 2012–2019
Figure 107: Immunization Rate (%), Australia, 2012–2018
Figure 108: PM2.5 (µg per m3), Australia, 2013–2019
Figure 109: CO2 Emissions (Million Tons), Australia, 2013–2020
Figure 110: Physicians (per 1,000 Population), Australia, 2013–2019
Figure 111: Dentists (per 1,000 Population), Australia, 2013–2019
Figure 112: Pharmacists (per 1,000 Population), Australia, 2013–2019
Figure 113: Nurses (per 1,000 Population), Australia, 2013–2019
Figure 114: Major Causes of Mortality (per 100,000 Population), Australia, 2019
Figure 115: Major Causes of Male Mortality (per 100,000 Population), Australia, 2019
Figure 116: Major Causes of Female Mortality (per 100,000 Population), Australia, 2019
Figure 117: DALYs by Major Disease (per 100,000 population), Australia, 2019
Figure 118: Healthcare Expenditure as Percentage of GDP (%), Australia, 2012–2019
Figure 119: Health Expenditure Share (% of Health Spending), Australia, 2013–2019
Figure 120: Healthcare Expenditure Components by Function (% of Total Health Expenditure), Australia, 2018
Figure 121: Pharmaceutical Spending (% of Total Health Spending), Australia, 2012–2018
Figure 122: Opportunities and Challenges